ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q2SCImago #8,529Hybrid

Journal of Biopharmaceutical Statistics

Acronym:lbps
•
Abbreviation (ISO):J. Biopharm. Stat
•
Identifier (ISSN):1054-3406(Print)/1520-5711(Online)
•
Publisher:Taylor and Francis Ltd.
Clarivate IF (2026)
1.3↑ +0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Biopharmaceutical Statistics

WoS Q4
01120.6420180.7620190.620201.0520211.520221.120231.220241.220251.32026
Annual Impact Factor Metric
Current (2026):1.3
Scopus SJR & RankScopus Q2
0.68
#8,529

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
60

60 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate16.7%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
48articles/year
4.09% Gold OA•98.7% Original Research

Aims & Scope

The Journal of Biopharmaceutical Statistics, a rapid publication journal, discusses quality applications of statistics in biopharmaceutical research and development. Now publishing six times per year, it includes expositions of statistical methodology with immediate applicability to biopharmaceutical research in the form of full-length and short manuscripts, review articles, selected/invited conference papers, short articles, and letters to the editor. Addressing timely and provocative topics important to the biostatistical profession, the journal covers: Drug, device, and biological research and development; Drug screening and drug design; Assessment of pharmacological activity; Pharmaceutical formulation and scale-up; Preclinical safety assessment; Bioavailability, bioequivalence, and pharmacokinetics; Phase, I, II, and III clinical development including complex innovative designs; Premarket approval assessment of clinical safety; Postmarketing surveillance; Big data and artificial intelligence and applications.

Topics Covered (Recognized by AI)
Mathematics91.7%Computer science84%Statistics83.2%Medicine76%Internal medicine62.4%Economics59.2%Biology57.6%Econometrics48.4%Pathology45.2%Machine learning42.1%Bioinformatics36.2%Artificial intelligence35.7%Physics35.1%Clinical trial28.4%Chemistry24.2%Philosophy20.7%Surgery20.6%Sample size determination20.4%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q4
Rank299/356
IndexSCIE
JCRSCIE2026

STATISTICS & PROBABILITY

Q2
Rank84/170
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q3
Rank197/356
IndexSCIE
JCISCIE2026

STATISTICS & PROBABILITY

Q2
Rank76/170
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.3
Articles / Year55
Total Citations0
2025
IF1.2
Articles / Year93
Total Citations51
2024
IF1.2
Articles / Year102
Total Citations150
2023
IF1.1
Articles / Year98
Total Citations352
2022
IF1.503
Articles / Year84
Total Citations422

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #8,529Scopus Q2SCImago Profile
Scopus Coverage:1991-2026
Scopus Broad Areas:MathematicsMedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.68

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
1.26

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,110 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations313
3-Year Documents216
Citable Documents200

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate42.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

PharmacologyQ2
Pharmacology (medical)Q2
Statistics and ProbabilityQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 16.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Biopharmaceutical Statistics (acronym: lbps, abbr: J. Biopharm. Stat, ISSN: 1054-3406) is a peer-reviewed international scholarly journal in the field of Medicine, published by Taylor and Francis Ltd. in United States since 1991. The periodical holds a Journal Impact Factor (JIF) of 1.30, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.680 (Q2), an H-index of 60.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 48 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,110 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Taylor and Francis Ltd.
Publication Language
English
Frequency
Bimonthly
Founding Year
1991
Indexing & Databases
SCIEScopusPubMed
Editorial Address
TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 2d8df94b-425e-44ab-8691-b6b19b1aef6f
Database Updated: 2026-09-29